Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2013; 34(01): 49
DOI: 10.4103/0971-5851.113435
LETTERS TO EDITOR

Unsectable cholangiocarcinoma: Additional therapy to chemoradiotherapy

Kamon Chaiyasit
Maefahlaung University Hospital, Bangkok, Thailand
,
Viroj Wiwanitkit
Hainan Medical University, China
› Author Affiliations
› Further Information
  PDF Download Permissions and Reprints


Publication History

Article published online:
20 July 2021

© 2013. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Leong E, Chen WW, Ng E, Van Hazel G, Mitchell A, Spry N. Outcomes from combined chemoradiotherapy in unresectable and locally advanced resected cholangiocarcinoma. J Gastrointest Cancer 2012;43:50-5.
  • 2 Wiwanitkit V. Clinical findings among 62 Thais with cholangiocarcinoma. Trop Med Int Health 2003;8:228-30.
  • 3 Gu MJ, Choi JH. Clinicopathological significance of E-Cadherin, β-Catenin and epidermal growth factor receptor expression in intrahepatic cholangiocarcinoma. Hepatogastroenterology 2012;59:116.